Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · IEX Real-Time Price · USD
3.385
-0.035 (-1.02%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Lisata Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
25
Market Cap
28.12M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cutera | 196.64M |
Equillium | 37.89M |
Accelerate Diagnostics | 12.17M |
Bolt Biotherapeutics | 11.32M |
Palatin Technologies | 5.90M |
Orgenesis | 529.00K |
LSTA News
- 8 days ago - Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy - GlobeNewsWire
- 10 days ago - Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line Cholangiocarcinoma - GlobeNewsWire
- 16 days ago - Lisata Therapeutics' Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical Model - GlobeNewsWire
- 6 weeks ago - Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial - GlobeNewsWire
- 2 months ago - Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events - GlobeNewsWire
- 2 months ago - Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer - GlobeNewsWire
- 2 months ago - Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024 - GlobeNewsWire